Investment
Features
FeesSafety
Academy
More
Pluang+

Class action lawsuit filed against iTonic Holdings for alleged securities fraud and pump-and-dump scheme.

Market News
17 Sep 2026
PRNewsWire
View Source
Bearish
Class action lawsuit filed against iTonic Holdings for alleged securities fraud and pump-and-dump scheme.

A class action lawsuit has been filed against iTonic Holdings Ltd (formerly Pheton Holdings Ltd) alleging securities fraud and a pump-and-dump scheme involving company officers, its auditor, and IPO underwriters. The lawsuit claims promoters spread false rumors, including a fake acquisition by Gilead Sciences, causing the stock price to collapse by about 95% in one day on July 29, 2025. Investors who bought shares during the class period can seek lead plaintiff status by September 28, 2026. The case highlights risks of fraudulent practices in stock promotions and may lead to financial recoveries for affected investors.

The class action lawsuit against iTonic Holdings Ltd is notable for investors tracking related market risks. For readers following Financials-sector stocks, here is Pluang's market snapshot as of Sep 17, 2026 20:41 WIB: out of 74 priced US Financials stocks, 56 rose and 17 fell today. Key movers include AVAT at USD 0.93 with a 1-day change of +3.93%, KKR at USD 99.60 with +2.85%, and CG at USD 40.97 with +2.40%.

More News

New crypto Pepeto raises $11.23M amid Ethereum's bullish $10,000 price forecast for 2026.

New crypto Pepeto raises $11.23M amid Ethereum's bullish $10,000 price forecast for 2026.

Pepeto, a new cryptocurrency on the Ethereum network, has quickly raised over $11.23 million in its presale, with each funding stage closing faster than the last. This momentum comes as Ethereum is predicted to reach $10,000 by the end of 2026, drive...

Market News
Bullish
31 minutes ago
BlackRock's stake in Fagron drops below 3% after share transfers, holding 2.96% voting rights as of October 2026.

BlackRock's stake in Fagron drops below 3% after share transfers, holding 2.96% voting rights as of October 2026.

BlackRock, Inc. disclosed that its voting rights in pharmaceutical company Fagron NV fell below the 3% reporting threshold due to the transfer of voting securities, despite acquiring financial instruments equivalent to voting rights. As of October 12...

Market News
Neutral
1 hour ago
FDA approves phentolamine eye drops for presbyopia, offering a new treatment for age-related near vision loss.

FDA approves phentolamine eye drops for presbyopia, offering a new treatment for age-related near vision loss.

Opus Genetics announced FDA approval of phentolamine ophthalmic solution 0.75% for treating presbyopia, an age-related condition affecting near vision in adults. This approval, based on successful Phase 3 trials, provides a non-invasive option that i...

Market News
Bullish
1 hour ago
K2 Vision performs 5,000 Light Adjustable Lens procedures, leading globally in this advanced vision tech.

K2 Vision performs 5,000 Light Adjustable Lens procedures, leading globally in this advanced vision tech.

K2 Vision has completed over 5,000 procedures using the Light Adjustable Lens (LAL), making it the highest-volume practice worldwide for this technology. The LAL is unique because it can be adjusted after implantation to fine-tune vision based on the...

Market News
Bullish
1 hour ago
BlackRock's stake in Fagron falls below 3% after share disposals, now holding 2.96% voting rights.

BlackRock's stake in Fagron falls below 3% after share disposals, now holding 2.96% voting rights.

BlackRock, Inc. disclosed that its shareholding in Fagron NV dropped below the 3% threshold to 2.96% after selling some voting securities, despite acquiring equivalent financial instruments. As of October 12, 2026, BlackRock holds 2,015,779 voting ri...

Market News
Neutral
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App